Cerus Corporation (CERS) Revenue Growth
Cerus Corporation (CERS) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 30.68% |
| 2018-12-31 | 48.17% |
| 2019-12-31 | 23.30% |
| 2020-12-31 | 21.83% |
| 2021-12-31 | 39.62% |
| 2022-12-31 | 18.05% |
| 2023-12-31 | -0.81% |
| 2024-12-31 | 7.78% |
| 2025-12-31 | 16.13% |
How CERS compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| FLGT | Fulgent Genetics Inc. | 13.83% |
| CI | The Cigna Group | 11.24% |
| NVST | Envista Holdings Corporation | 8.32% |
| BDX | Becton Dickinson and Company | 8.24% |
| CVS | CVS Health Corporation | 7.85% |
These are five companies in the same sector as CERS with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Cerus Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("CERS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CERS | $2.59 | +0.78% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 |